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Foot-and-mouth  disease  (FMD)  is  endemic  to  sub-
Saharan Africa. To further understand its complex epide-
miology, which involves multiple virus serotypes and host 
species, we characterized the viruses recovered from FMD 
outbreaks in Ethiopia during 1981–2007. We detected 5 of 
the 7 FMDV serotypes (O, A, C, Southern African Territories 
[SAT] 1, and SAT 2). Serotype O predominated, followed 
by serotype A; type C was not recognized after 1983. Phy-
logenetic analysis of virus protein 1 sequences indicated 
emergence of a new topotype within serotype O, East Africa 
4. In 2007, serotype SAT 1 was detected in Ethiopia and 
formed a new distinct topotype (IX), and serotype SAT 2 
reappeared after an apparent gap of 16 years. The diversity 
of viruses highlights the role of this region as a reservoir for 
FMD virus, and their continuing emergence in Ethiopia will 
greatly affect spread and consequent control strategy of the 
disease on this continent.
F
oot-and-mouth disease virus (FMDV) is the causative 
agent of a highly contagious and economically devas-
tating disease of cloven-hooved domestic and wild animals. 
It can cause a high number of deaths among young animals 
and production losses in adults and is the single most lim-
iting constraint to international trade of live animals and 
animal products. FMDV belongs to the genus Aphthovirus 
in the family Picornaviridae and possesses a single strand 
of  positive-sense  RNA  genome.  It  has  a  high  mutation 
rate because the viral RNA–dependent RNA polymerase 
lacks proofreading ability, resulting in 7 immunogenically 
distinct serotypes (O, A, C, Southern African Territories 
[SAT] 1, SAT 2, SAT 3, and Asia 1) and numerous and 
constantly evolving variants showing a spectrum of anti-
genic diversity. Vaccination is an effective way to control 
FMD; however, the protection conferred by vaccination or 
infection is usually serotype specific and sometimes incom-
plete within a serotype (1–3).
FMD is endemic to sub-Saharan Africa; widespread 
outbreaks of clinical disease occur during most years (4,5). 
Of the 7 serotypes (except Asia 1), 6 have reportedly oc-
curred on the continent, and disease control becomes more 
complicated because of marked regional differences in the 
distribution and prevalence of various serotypes and intra-
typic variants (4–6). FMD was first recorded in Ethiopia 
in 1957 when serotypes O and C were detected (7,8). Se-
rotypes A and SAT 2 were not identified until 1969 and 
1989, respectively (8,9). During 1988–1991, analysis of 
outbreak samples from Ethiopia at the National Veterinary 
Institute (NVI), Debre Zeit, Ethiopia, and at the Food and 
Agriculture  Organization  World  Reference  Laboratory 
for  Foot-and-Mouth  Disease  (WRLFMD),  Institute  for 
Animal Health, Pirbright, UK, identified serotype O and 
serotype SAT 2 FMDV as the causative agents (9). The 
occurrence of FMD in Ethiopia has apparently increased 
since 1990; outbreaks throughout the country are reported 
frequently (10). FMD remains largely uncontrolled in the 
country because vaccination for prophylactic purpose is 
not being practiced except for a few dairy herds containing 
exotic animals. With no control and preventive measures 
in place, FMD causes substantial economic loss to farmers 
and to the nation from embargoes of livestock and livestock 
product trade (11). To initiate control measures for FMD, 
the following must be identified: origin of infection, links 
between outbreaks, extent of genetic variation of the caus-
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ative viruses, and antigenic relationship of field isolates to 
the available vaccines.
Phylogenetic analysis of the virus protein (VP) 1 region 
of FMD viruses has been used extensively to investigate the 
molecular epidemiology of the disease worldwide. These 
techniques have helped define genetic relationships between 
FMDV isolates and geographic distribution of lineages and 
genotypes; they have also helped establish genetically and 
geographically linked topotypes and trace the source of out-
breaks  (4,6,12).  Topotypes  are  defined  as  geographically 
clustered viruses that form a single genetic lineage generally 
sharing >85% (O, A, C, and Asia 1) or >80% (SAT 1, SAT 
2, and SAT 3) nucleotide identity in the VP1-coding region.
We report the circulation of 4 of 7 serotypes of FMDV 
in Ethiopia: serotype O, serotype A, serotype SAT 2, and 
serotype SAT 1. Emergence of these viruses in Ethiopia 
will greatly affect spread and consequent control strategy 
of the disease on this continent because restriction of ani-
mal movement between many African countries is limited.
Materials and Methods
During  1981–2007,  epithelial  tissues  and  vesicular 
fluids were collected from FMD-suspected animals from 
different areas of Ethiopia and submitted to NVI in Debre 
Zeit. Bovine samples were collected throughout the coun-
try; swine samples were collected only from 1 swine farm 
(Alagae) in Zeway, Eastern Shoa, during 1986 and 1998; 
and ovine and caprine samples were collected from Mizan 
Teferi, Bench Maji, in 2007. No samples came from eastern 
Ethiopia. The samples were transported from the collection 
site to the diagnostic laboratory in 0.04 M phosphate buffer 
(pH 7.2–7.6) with 50% glycerol at 4°C (13) and stored at 
–20°C until tested (14). When possible, the same samples, 
or others collected at the same time as those tested at NVI, 
were also submitted to the WRLFMD in Pirbright for ad-
ditional studies.
Laboratory Diagnosis
Viruses were isolated and serotypes were identified as 
follows. Established cell layers of either IB-RS-2 (porcine 
kidney) or BHK-21 (baby hamster kidney) at NVI or pri-
mary BTy (bovine thyroid) cells at WRLFMD were inocu-
lated with the suspension of suspected material. Cytopathic 
effects were noted after 24–48 hours in positive samples. If 
no cytopathic effect was detected, the cells were passaged 
at least 1× more before the samples were declared nega-
tive. Serotyping of FMDV was carried out by complement 
fixation test at NVI (13) and by antigen-detection ELISA at 
WRLFMD (15).
Viruses and Primers
A selection of 81 viruses submitted to WRLFMD was 
further characterized by sequencing of the VP1 gene. The 
designation and origin of FMDV isolates studied are list-
ed in online Technical Appendix Table 1 (available from 
www.cdc.gov/EID/content/15/9/1409-Techapp.pdf). Three 
alternative primer combinations were used for the reverse 
transcription–PCR  (RT-PCR)  of  FMDV  serotype  O  vi-
ruses:  O-1C244F/EUR-2B52R,  O-1C272F/EUR-2B52R, 
and O-1C283F/EUR-2B52R. Two primer sets were used 
for each of the other serotypes: serotype A (A-1C562F/
EUR-2B52R  and  A-1C612F/EUR-2B52R),  serotype  C 
(C-1C536F/EUR-2B52R and C-1C616F/EUR-2B52R), se-
rotype SAT 1 (SAT1-1C559F/SAT-2B208R and SAT-1U-
OS/SAT-2B208R), and serotype SAT 2 (SAT2-P1-1223F/
SAT  2B208R  and  SAT2-1C445F/SAT-2B208R)  (online 
Technical Appendix Table 2). Additional internal sequenc-
ing primers were used to ensure coverage of the VP1 region 
on both strands (online Technical Appendix Table 2).
RT-PCR of Virus RNA
RNA extraction and RT-PCR were conducted accord-
ing to the protocol described previously (16), except for 
the following. The thermal profiles used for amplification 
of the VP1 sequence of various serotypes were as follows: 
FMDV O: 42°C for 30 min, 94°C for 5 min, 35 cycles of 
94°C for 60 s, 60°C for 60 s, and 72°C for 90 s, followed 
by a final extension of 72°C for 5 min. Conditions were 
the same for the other serotypes, except that extension tem-
peratures were 55°C for A and C and 50°C for SAT 1 and 
SAT 2. After PCR, deoxyribonucleotide triphosphates and 
primers were removed by using GFX PCR DNA and Gel 
Band Purification Kit (GE Healthcare, Buckinghamshire, 
UK)  according  to  the  manufacturer’s  instructions.  The   
purified PCR product was stored at –20°C until used.
DNA Sequencing
PCR  amplicons  were  sequenced  by  using  the  DTS 
Quick Start Kit (Beckman Coulter, Fullerton, CA, USA) 
according to the manufacturer’s instructions and the se-
quencing primers listed in online Technical Appendix Ta-
ble 2. The sequencing reactions were run on a CEQ8000 
Automated Sequencer (Beckman Coulter) according to the 
manufacturer’s instructions. Sequences determined in this 
study have been submitted to the EMBL/GenBank/DDBJ 
databases; accession numbers are shown in online Techni-
cal Appendix Table 1.
Phylogenetic Analyses
Total RNA was extracted from 81 FMD viruses in 
Ethiopia,  and  each  VP1-coding  region  was  successfully 
amplified by RT-PCR. The PCR products were directly 
sequenced  on  both  strands  to  obtain  the  complete  VP1 
sequences, which were compared with the other relevant 
FMDV VP1 sequences within the same serotype (see Fig-
ures 1–5 for database accession numbers).
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VP1 nucleotide sequences were aligned by using Bio-
Edit 7.0.5.3 (17) and Clustal W (18). These alignments were 
used to construct distance matrices by using the Kimura 
2-parameter nucleotide substitution model in the program 
MEGA 4.0 (19). Some previously published sequences of 
serotype O were incomplete at the 5′ end of the VP1 gene 
and consisted of 495 nucleotides rather than the full-length 
639  nucleotides.  Midpoint-rooted  neighbor-joining  trees 
were then constructed with MEGA 4.0 software. The robust-
ness of the tree topology was assessed with 1,000 bootstrap 
replicates by using the model in MEGA 4.0. The serotype 
C sequences labeled PD-FMD in Figure 3 were supplied by 
the Project Directorate on FMD, Mukteswar, India (20).
Vaccine Strain Selection
Vaccine strain selection for Ethiopian serotype O iso-
lates was performed at WRLFMD by using the virus neu-
tralization test. Relationship (r1) values were determined as 
described elsewhere (21). An r1 value of >0.3 was consid-
ered a good match with the vaccine strain (22).
Results
Distribution of FMD
FMD outbreaks occurred every year, but most (821) 
were reported in 1999 (Figure 6). This finding is consistent 
with previously reported findings (10,23) but is probably an 
underrepresentation of the actual situation. Of the 269 out-
break samples examined, FMDV was isolated from 82.2% 
(Table 1). During 1981–2007, a total of 5 serotypes (O, A, 
C, SAT 1, and SAT 2) were identified in bovine, swine, 
ovine,  and  caprine  samples  collected  from  the  outbreak 
areas. FMDV O was the dominant serotype (73.3%), fol-
lowed by types A (19.5%), SAT 2 (4.1%), SAT 1 (1.8%), 
and C (1.3%). 
Geographically, the outbreaks were widely distribut-
ed. Most were within central Ethiopia, including the Ad-
dis Ababa administrative region; the rest were in Ahmara 
and Tigray in the north, Dire Dawa in the northeast, Bene-
shangul-Gumuz bordering Sudan in the west, and Southern 
Nations Nationalities and Peoples Region bordering Kenya 
and Sudan in the south (Figure 7). In eastern Ethiopia, poor 
veterinary  services  and  inaccessibility  to  the  area  could 
have resulted in the lack of samples submitted.
In terms of species, cattle were found to be infected 
with all circulating serotypes of FMDV, whereas swine had 
only type O (Tables 1 and 2). SAT 2 was recorded in 2007, 
after an apparent gap of 16 years, from a bovine sample col-
lected from Bambas, Beneshangul-Gumuz, western Ethio-
pia bordering Sudan (Figure 7, panel B). The first recorded 
occurrence of FMDV type SAT 1 in Ethiopia was identified 
from a bovine sample collected in November 2007 from 
the Mizan Teferi area bordering Kenya (Figure 7, panel B). 
Analysis of the samples collected from the same region 1 
month later, in December 2007, showed involvement of 3 
species: cattle, sheep, and goats.
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Figure  1.  Midpoint-rooted  neighbor-joining  tree  (based  on  the 
complete  virus  protein  [VP]  1  coding  sequence)  showing  the 
relationships between the foot-and-mouth disease virus serotype 
O isolates from Ethiopia and other contemporary and reference 
viruses. The 3 isolates from 2005 forming a new topotype East 
African (EA)-4 are boxed. The year in parenthesis indicates the year 
of sample collection. Scale bar indicates substitutions per site. *Not 
a reference number assigned by the World Reference Laboratory 
for Foot-and-Mouth Disease, Pirbright, UK. †Partial (495-nt) VP1 
sequence used.
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Phylogenetic Analyses
Serotype O
Of the FMDVs examined, serotype O predominated. 
All but 3 of the 55 FMDV serotype O Ethiopia isolates ex-
amined in our study fell into a single topotype, East Af-
rica (EA)-3 (Figure 1). These 3 samples from 2005 were 
collected from cattle in the Mizan Teferi area (southwest 
of Addis Ababa) and formed a new serotype O topotype, 
which we named EA-4. Four viruses from Uganda in 1998 
(≈91% nucleotide identity) also belonged to this topotype. 
The VP1 sequences of viruses within EA-4 differed by 
≈14%–16% from members of the EA-1, EA-2, and EA-3 
topotypes. Ethiopia type O viruses isolated during 2003–
2007 fell into 6 lineages (A–F; Figure 1), which appeared 
to be cocirculating in different geographic regions (Figure 
7, panel A; online Technical Appendix Table 1).
Serotype A
All viruses from Ethiopia belonged to the AFRICA 
topotype (Figure 2) (6). Three distinct lineages compris-
ing viruses from Ethiopia were evident; all had high boot-
strap support. Lineage A (1979 and 1981) also contained 
a single virus from Egypt in 1972; lineage B (1992–2002) 
contained only viruses from Ethiopia; and lineage C (2007) 
also contained viruses from Kenya (1998 and 2005) and 
Egypt (2006). Lineage B spanned 11 years and contained 
viruses isolated from 4 main regions—Oromiya, Tigray, 
Dire Dawa, and Southern Nations Nationalities and Peoples 
Region—indicating widespread dispersal of type A viruses 
(Figure 2). The virus isolated in 2007 (A/ETH/4/2007) was 
more closely related to the virus isolated from Kenya in 
2005 (≈5% nt difference) than to that isolated from Ethio-
pia in 2000–2002 (≈10% nt difference).
Serotype C
Serotype C was not identified after 1983. Phylogenetic 
analysis showed that all serotype C viruses from Africa 
belonged to a single lineage (Figure 3), which has been 
designated the AFRICA topotype (N.J. Knowles, unpub. 
data). The 2 virus isolates from 1983 were closely related 
to a virus from Ethiopia in 1971 (≈98.5% nt identity) and 
grouped with the Kenya vaccine strain, K267/67 (≈94% nt 
identity) (Figure 3).
Serotypes SAT 1 and SAT 2
Genetic characterization of the newly identified SAT 
1 isolates from Ethiopia indicates that they are all closely 
related but distinct from all other SAT 1 viruses from East 
Africa examined in this study (Figure 4). They were most 
closely related to viruses from Niger and Nigeria during 
1975–1976 (topotype V) (24) but were different enough 
(SAT1/ETH/4/2007 vs. SAT1/NIG/11/75, 23% nt differ-
ence) to be classified as a new topotype, which we named 
topotype IX. 
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Figure  3.  Midpoint-rooted  neighbor-joining  tree  (based  on  the 
complete  virus  protein  [VP]  1  coding  sequence)  showing  the 
relationships between the foot-and-mouth disease virus serotype 
C  isolates  from  Ethiopia  (boxed)  and  other  contemporary  and 
reference viruses. The year in parenthesis indicates the year of 
sample collection. Scale bar indicates substitutions per site. *Not a 
reference number assigned by the World Reference Laboratory for 
Foot-and-Mouth Disease, Pirbright, UK. 
 A/EGY/1/2006 (EF208757)
 A/EGY/2/2006 (EF208758)
 A/EGY/4/2006 (EF208760)
 A/EGY/3/2006 (EF208759)
 A/EGY/5/2006 (EF208761)
 A/KEN/29/2005 (EF208773)
 A/ETH/4/2007
 A/KEN/15/98 (EF208774)
 A/KEN/16/98A (EF208775)
 A/ETH/7/92 (EF208765)
 A/ETH/23/94 (EF208767)
 A/ETH/1/94 (EF208766)
 A/ETH/3/2005 (year nk) (EF208762)
 A/ETH/4/2005 (2000) (EF208763)
 A/ETH/16/2005 (2000/01) (EF208764)
 A/ETH/6/2000
 A/ETH/9/2005 (2000)
 A/ETH/10/2005 (2002)
 A/K37/84* (EU414532)
 A/CAR/15/2000 (EF208755)
 A21/Lumbwa/KEN/64 (AY593761)
 A/EGY/1/72 (EF208756)
 A/ETH/2/79 (1974)
 A/ETH/13/2005 (1981)
 A/ETH/14/2005 (1981)
 A/GAM/44/98 (EF208768)
 A/MAI/2/97 (EF208776)
 A23/Kitale/KEN/64 (AY593766)
Africa
 A/Trenquelauquen/ARG/2001 (AY593786)
 A/MOR/7/77 (EU553870)
 A24/Cruzeiro/BRA/55 (AJ251476)
 A10/HOL/42 (M20715)
 A12/UK/119/32 (M10975)
 A/LIB/4/79 (EU553868)
 A5/Allier/FRA/60 (AY593780)
 A/MOR/8/83 (EU553871)
Euro-SA
 A/IND/17/77* (AF204108)
 A22/IRQ/24/64 (AJ251474)
 A/IRN/1/96 (EF208771)
 A/SAU/23/86 (EU414536)
 A/IRN/2/87 (EF208770)
 A/IRN/1/2005 (EF208769)
 A/IRN/22/99 (EF208772)
Asia
87
100
96
100
100
100
90
72
99
89 83
89
97
99
99
99
100 95
100
95
96
99
98
83
72
91
98
0.02
A
B
C
Figure  2.  Midpoint-rooted  neighbor-joining  tree  (based  on  the 
complete  virus  protein  [VP]  1  coding  sequence)  showing  the 
relationships between the foot-and-mouth disease virus serotype A 
isolates from Ethiopia and other contemporary and reference viruses. 
The isolate from 2007 is boxed. The year in parenthesis indicates 
the year of sample collection. Scale bar indicates substitutions per 
site. *Not a reference number assigned by the World Reference 
Laboratory for Foot-and-Mouth Disease, Pirbright, UK.Foot-and-Mouth Disease Viruses, Ethiopia, 1981–2007
The first isolation of SAT 2 was in 1989 from a sample 
collected from cattle raised on Leben Ranch, Borena Zone, 
in southern Ethiopia (9); the virus was detected for the next 
2 years but not again until 2007, an apparent gap of 16 
years. Phylogenetic analysis of SAT 2 viruses from Ethi-
opia shows 3 distinct topotypes: IV (isolates from 1989), 
XIV (isolates from 1991), and XIII (single isolate from 
2007) (Figure 5). Topotype IV has been detected in other 
African countries (Burundi, Malawi, Kenya, and Tanza-
nia); topotype XIV was isolated only from Ethiopia. The 
new 2007 SAT 2 isolate from Beneshangul-Gumuz, Ethio-
pia (regional state bordering Sudan), did not group under 
either of the above-mentioned topotypes; rather, it could 
be  assigned  to  topotype  XIII  along  with  Sudan  isolates 
(SUD/6/77 and SUD/9/77, ≈81% nt identity) supported by 
a bootstrap value of 99% (Figure 5).
Vaccine Strain Selection
For  vaccine  strain  selection  for  the  new  topotype 
of serotype O FMDV (EA-4), serologic tests were con-
ducted.  The  extent  of  in  vitro  cross-neutralization  of   
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Figure  4.  Midpoint-rooted  neighbor-joining  tree  (based  on 
the  complete  virus  protein  1  coding  sequence)  showing  the 
relationships between the foot-and-mouth disease virus serotype 
Southern African Territories (SAT) 1 isolates from Ethiopia and other 
contemporary and reference viruses. The 4 isolates from Ethiopia 
in 2007 are boxed. The year in parenthesis indicates the year of 
sample collection. Scale bar indicates substitutions per site. *Not a 
reference number assigned by the World Reference Laboratory for 
Foot-and-Mouth Disease, Pirbright, UK.
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Figure  5.  Midpoint-rooted  neighbor-joining  tree  (based  on 
the  complete  virus  protein  1  coding  sequence)  showing  the 
relationships between the foot-and-mouth disease virus serotype 
Southern African  Territories  (SAT)  2  isolates  from  Ethiopia  and 
other  contemporary  and  reference  viruses.  The  SAT  2  isolates 
from Ethiopia under lineage IV, XIII, and IVX are boxed. The year 
in parenthesis indicates the year of sample collection. Scale bar 
indicates substitutions per site. *Not a reference number assigned 
by the World Reference Laboratory for Foot-and-Mouth Disease, 
Pirbright, UK.RESEARCH
O/ETH/58/2005 by antiserum against serotype O vaccine 
strains was evaluated. The match against vaccine strains O1 
Manisa and O1 Lausanne were above the cutoff value of 0.3 
(r1 0.42 and 0.32, respectively), which indicated that both 
strains can confer protection for the new topotype (22). 
Similarly, representative samples from topotype EA-3 (O/
ETH/9/2005 and O/ETH/10/2005) showed the O1 Manisa 
vaccine strain to be the vaccine of choice (r1 0.63 and 0.52, 
respectively).
Discussion
Similar  to  our  findings,  previous  studies  also  have 
indicated serotype O to be highly prevalent and a domi-
nant serotype causing most of the outbreaks in Ethiopia 
(7,8,23). The molecular epidemiology of serotype O has 
been well studied (6,12). Our study showed the existence 
of a fourth FMDV serotype O EA topotype. On the basis 
of comparison of sequence data of the VP1 gene, existence 
of 8 serotype O topotypes has been demonstrated within 
samples collected around the world (12). Among those, 
2 topotypes were found in Africa, 1 in East Africa, and 1 
in West Africa. Sangare et al. (25) described 7 genotypes 
of serotype O virus, 4 of which contained isolates from 
Africa. Samuel and Knowles (12) reported that isolates 
from Kenya and Uganda formed part of a single East Af-
rican topotype (EA); viruses from Ethiopia, Tanzania, and 
Eritrea belonged to the Middle East–South Asia (ME-SA) 
topotype. However, their study was based on partial VP1 
sequence data (3′ end of the gene), and it has been sug-
gested that the relationships observed may have resulted 
from previous recombination events (26). Knowles et al. 
(26) renamed the EA topotype as EA-1 and identified 2 
additional EA topotypes: EA-2 in Burundi, Kenya, Mala-
wi, Rwanda, Tanzania, Uganda, and northern Zambia and 
EA-3 in Eritrea, Ethiopia, and Sudan.
Since  1983,  serotype  C  seems  to  have  disappeared 
from Ethiopia (Figure 3). However, a recent report of se-
rotype C–specific antibodies in cattle in Ethiopia (27) in-
dicates that circulation of serotype C viruses in Ethiopia 
may have gone unnoticed. No outbreaks of serotype C have 
been reported in Europe since 1989 (Italy), in South Amer-
ica since 2004 (Brazil), in Asia since 1995 (India and the 
Philippines) or 1996 (Nepal), and in Africa since 2004 (Ke-
nya) (28). Therefore, investigations of the epidemiology of 
serotype C viruses in Ethiopia are urgently needed.
Genetic characterization of SAT type viruses is well 
documented for the southern African region; emphasis has 
been on viruses isolated from the African buffalo (Synce-
rus caffer) (29–32) and on cattle viruses from West Africa 
(33) and East Africa (24). On the basis of nucleotide se-
quence analysis of a portion of the viral genomes obtained 
from buffalo and domestic animals in sub-Saharan Africa, 
14  independently  evolving  viral  genotypes  were  identi-
fied for SAT 2, 8 for SAT 1, and 6 for SAT 3 (5). FMDV 
SAT 1 was first isolated in Ethiopia (Bench Maji, South-
ern  Nations  Nationalities  and  Peoples  Region)  in  2007 
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Figure  7.  Location  of  cases  of  various  foot-and-mouth  disease 
(FMD) virus serotypes in the outbreaks of FMD, Ethiopia, 1981–
2007, as evidenced by laboratory diagnosis. A) Serotype O, B) 
serotypes A, C, Southern African Territories (SAT) 1, and SAT 2. All 
boundaries are approximate and unofficial. Original map produced 
by United Nations Emergencies Unit for Ethiopia, 2000.
Figure 6. Number of foot-and-mouth disease outbreaks per year 
in different parts of the country, 1997–2007. Data from Ministry of 
Agriculture and Rural Development, Ethiopia; data for 1981–1996 
not available.
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from samples collected from 3 species: cattle, sheep, and 
goats. Although SAT 1 has not been previously reported 
in Ethiopia (7,8,24), it might be circulating within wildlife 
and infrequently transmitted to domestic animals. SAT 2 
may have been recently introduced by animal movement 
across the border with Sudan because SAT 2 is endemic to 
Sudan (5,34). Recent presence of serotype SAT 2–specific 
antibodies in cattle in Ethiopia has been reported (27). Two 
explanations are possible: 1) the virus is present in Ethio-
pia but has not been detected because all outbreaks are not 
reported or investigated, or 2) type SAT 2 viruses circulate 
subclinically in Ethiopia, possibly in wildlife.
FMD is endemic to Ethiopia as it is in all the bordering 
countries—Eritrea in the northeast, Sudan in the west, Ke-
nya in the south, and Somalia in the east—and restriction of 
animal movement is limited. A large number of wildlife, in-
cluding African buffalo (particularly in the Mago and Omo 
national parks), could act as FMDV reservoirs. The asso-
ciation of SAT serotypes with wildlife, particularly African 
buffalo, has been indicated (5,24,35,36). Individual buffalo 
can harbor the virus for as long as 5 years, and an isolated 
buffalo herd can maintain FMDV for 24 years (37). Trans-
mission of virus from infected buffalo to other susceptible 
animals in close contact has been demonstrated (38–40). 
Therefore, transmission of FMDV by cattle movement or 
from wild animals to domestic animals is likely and may 
play a role in FMD outbreaks and in the appearance of new 
topotypes in Ethiopia.
The veterinary infrastructure for FMD disease surveil-
lance and also the outbreak reporting system, which have 
not been efficient because of things such as financial con-
straints and difficulty accessing some regions, has improved 
considerably since the 1990s. Hence, this study may not 
be a true reflection of the number of serotypes/topotypes 
present in Ethiopia because not all outbreaks are reported 
or investigated due to the endemic nature of the disease. 
Therefore, comprehensive studies, including wildlife for 
molecular epidemiology and representative samples from 
all regions, are needed.
In terms of selecting vaccine strains, assessing the 
threat of SAT 1 and SAT 2 viruses in Ethiopia is difficult 
because SAT viruses often appear sporadically and then 
disappear in Ethiopia (only 1 SAT 1 and 4 SAT 2 sam-
ples have been isolated in 2007, and to date, no SAT out-
break has been reported in Ethiopia). Therefore, regular 
monitoring of the circulation of these viruses in livestock 
may help with selection of appropriate vaccine strains for 
FMD control.
In conclusion, the epidemiology of FMD in Ethiopia 
is complex because multiple serotypes of the virus (O, A, 
SAT 1, and SAT 2) circulate, 4 host species (cattle, sheep, 
goats, and pig) are involved, and high numbers of wildlife 
(especially African buffalo) cross the borders of neighbor-
ing countries uncontrolled. In addition, lack of prophylac-
tic vaccination and veterinary infrastructure to handle out-
breaks on a large scale greatly contribute to the frequent 
occurrence of the disease and make control of FMD ex-
tremely challenging. Regular monitoring and more detailed 
investigation are needed to formulate an efficient vaccine-
based FMD control strategy for Ethiopia.
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